TY - JOUR T1 - A validated risk model for prediction of early readmission in patients with hepatic encephalopathy JO - Annals of Hepatology T2 - AU - Kruger,Andrew J. AU - Aberra,Fasika AU - Black,Sylvester M. AU - Hinton,Alice AU - Hanje,James AU - Conteh,Lanla F. AU - Michaels,Anthony J. AU - Krishna,Somashekar G. AU - Mumtaz,Khalid SN - 16652681 M3 - 10.1016/j.aohep.2018.08.001 DO - 10.1016/j.aohep.2018.08.001 UR - https://www.elsevier.es/en-revista-annals-hepatology-16-articulo-a-validated-risk-model-for-S1665268119300079 AB - Introduction and aimHepatic encephalopathy (HE) is a common complication in cirrhotics and is associated with an increased healthcare burden. Our aim was to study independent predictors of 30-day readmission and develop a readmission risk model in patients with HE. Secondary aims included studying readmission rates, cost, and the impact of readmission on mortality. Materials and methodsWe utilized the 2013 Nationwide Readmission Database (NRD) for hospitalized patients with HE. A risk assessment model based on index hospitalization variables for predicting 30-day readmission was developed using multivariate logistic regression and validated with the 2014 NRD. Patients were stratified into Low Risk and High Risk groups. Cox regression models were fit to identify predictors of calendar-year mortality. ResultsOf 24,473 cirrhosis patients hospitalized with HE, 32.4% were readmitted within 30 days. Predictors of readmission included presence of ascites (OR: 1.19; 95% CI: 1.06–1.33), receiving paracentesis (OR: 1.43; 95% CI: 1.26–1.62) and acute kidney injury (OR: 1.11; 95% CI: 1.00–1.22). Our validated model stratified patients into Low Risk and High Risk of 30-day readmissions (29% and 40%, respectively). The cost of the first readmission was higher than index admission in the 30-day readmission cohort ($14,198 vs. $10,386; p-value <0.001). Thirty-day readmission was the strongest predictor of calendar-year mortality (HR: 4.03; 95% CI: 3.49–4.65). ConclusionsNearly one-third of patients with HE were readmitted within 30 days, and early readmission adversely impacted healthcare utilization and calendar-year mortality. With our proposed simple risk assessment model, patients at high risk for early readmissions can be identified to potentially avert poor outcomes. ER -